RBC Europe’s Avanos Medical AVNS Stock Holding History

RBC Europe’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Hold	77	–	–	﹤0.01%	578
2022 Q1	$3K	Hold	77	–	–	﹤0.01%	581
2021 Q4	$3K	Sell	77 -135	-64%	-$4.37K	﹤0.01%	581
2021 Q3	$6.61K	Hold	212	–	–	﹤0.01%	1006
2021 Q2	$7.71K	Hold	212	–	–	﹤0.01%	999
2021 Q1	$9.27K	Hold	212	–	–	﹤0.01%	923
2020 Q4	$9.73K	Hold	212	–	–	﹤0.01%	885
2020 Q3	$7.04K	Hold	212	–	–	﹤0.01%	862
2020 Q2	$6.23K	Hold	212	–	–	﹤0.01%	844
2020 Q1	$5.71K	Hold	212	–	–	﹤0.01%	815
2019 Q4	$7.14K	Hold	212	–	–	﹤0.01%	858
2019 Q3	$7.94K	Hold	212	–	–	﹤0.01%	829
2019 Q2	$9.24K	Sell	212 -27	-11%	-$1.16K	﹤0.01%	817
2019 Q1	$10.2K	Hold	239	–	–	﹤0.01%	812
2018 Q4	$10.7K	Sell	239 -17	-7%	-$891	﹤0.01%	768
2018 Q3	$17.5K	Hold	256	–	–	﹤0.01%	710
2018 Q2	$14.7K	Hold	256	–	–	﹤0.01%	751
2018 Q1	$11.8K	Sell	256 -87	-25%	-$4.13K	﹤0.01%	797
2017 Q4	$15.8K	Sell	343 -228	-40%	-$10.5K	﹤0.01%	742
2017 Q3	$25.7K	Buy	+571	New	+$24.4K	﹤0.01%	630

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

RBC Europe's AVNS Position: Q2 2022 in Review

RBC Europe held its Avanos Medical (AVNS) position steady in Q2 2022 at 77 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

RBC Europe first reported a position in AVNS in Q3 2017 and has held it in 20 quarters since. The position peaked at $25.7K in Q3 2017. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

RBC Europe held 77 shares of Avanos Medical worth $2K as of Q2 2022.
RBC Europe left its Avanos Medical share count unchanged in Q2 2022.
Avanos Medical made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #578 holding.
RBC Europe first reported a position in Avanos Medical in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Avanos Medical position peaked at $25.7K in Q3 2017.
287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.